skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

20 studies were found about pyrazinamide

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000636

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000638

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000950

Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis

Condition: HIV Infections; Acquired Immunodeficiency Syndrome; Tuberculosis

NCT ID: NCT00698334

The Treatment of Tuberculosis in HIV-Infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00001033

Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis

Condition: Tuberculosis; Human Immunodeficiency Virus Infections

NCT ID: NCT00376012

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000796

Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3

Condition: HIV-1 Infection

NCT ID: NCT02057796

A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00402610

Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis

Condition: HIV Infection; Pulmonary TB

NCT ID: NCT00933790

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment

Condition: HIV Infection

NCT ID: NCT01380080

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00004736

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana

Condition: Tuberculosis; HIV

NCT ID: NCT01687504

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV

Condition: HIV Infection; Tuberculosis

NCT ID: NCT01601626

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

Condition: HIV Infections

NCT ID: NCT00402454

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)

Condition: Tuberculosis; HIV

NCT ID: NCT01637558

Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes

Condition: AIDS With Tuberculosis

NCT ID: NCT01782950

Tuberculosis Treatment Shortening Trial

Condition: Tuberculosis

NCT ID: NCT00130247

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Condition: HIV Infections

NCT ID: NCT00042289

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Condition: Tuberculosis

NCT ID: NCT01222338